New persistent opioid use after colorectal surgery in Sweden: A nationwide register‐based cohort study
Colorectal Disease · 2026
DOI: 10.1111/codi.70601 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Colorectal Disease, 2026. Verfasst von Claes Gedda und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery and Anaesthesiology, Ersta Hospital, Stockholm, Sweden. Hauptthemen laut MEDLINE: Analgesics, Opioid, Postoperative Pain, Elective Surgical Procedures, Opioid-Related Disorders. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stockholm läns landsting, Ersta Forskningsavdelning, Erling-Persson Family Foundation.
Abstract (Originalsprache)
Aim
To determine the incidence of new persistent opioid use (NPOU) after elective colorectal surgery in Sweden and to identify associated patient‐, procedure‐ and hospital‐level factors.
Method
This nationwide retrospective cohort study linked data from Swedish national health registries and included adults undergoing elective inpatient colorectal surgery between 2018 and 2022. Patients with an opioid dispensed 365 to 30 days before surgery, another surgical procedure within one year of the index operation, or death within 12 months postoperatively were excluded. NPOU was defined as at least one opioid dispensed within 90 days after surgery and at least one between 90 and 180 days. Associations were examined using multivariable logistic regression.
Results
Among 14,233 opioid‐naïve patients, 374 (2.63%; 95% CI, 2.37–2.90%) developed NPOU. Longer operating time (aOR, 1.19 per hour; 95% CI, 1.13–1.26), preoperative non‐opioid analgesics (aOR, 1.90; 95% CI, 1.52–2.37) or sedatives/anxiolytics (aOR, 1.66; 95% CI, 1.31–2.09), opioid dispensation within 7 days of surgery (aOR, 2.19; 95% CI, 1.76–2.72), and higher ASA classification (ASA 3: aOR, 1.89; 95% CI, 1.26–2.90; ASA 4: aOR, 3.29; 95% CI, 1.63–6.36) were independently associated with higher odds of NPOU, whereas male sex was associated with lower odds (aOR, 0.76; 95% CI, 0.61–0.95).
Conclusion
In this low‐prescribing setting, approximately one in 38 opioid‐naïve patients developed NPOU 6 months after colorectal surgery. Operating time and opioid dispensation within 7 days of surgery were independently associated with NPOU; the latter, a modifiable prescribing decision, is a plausible target for opioid‐sparing strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery and Anaesthesiology, Ersta Hospital, Stockholm, Sweden.
- Department of Clinical Science, Danderyds Hospital, Karolinska Institute, Stockholm, Sweden.
- Department of Translational Medicine, Faculty of Medicine, Lund University, Malmö, Sweden.
- Department of Communicable Disease Control and Preparedness, Public Health Agency of Sweden, Solna, Sweden.
- Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.
- Department of Inflammatory Bowel Disease and Intestinal Failure Surgery, Karolinska University Hospital, Stockholm, Sweden.
ORCID-Profile: Claes Gedda, Jonas Nygren, Erik Sturegård, Yunzhang Wang, Mattias Soop
Förderung
- Stockholm läns landsting
- Ersta Forskningsavdelning
- Erling-Persson Family Foundation
Zitieren
APA
Gedda, C., Nygren, J., Sturegård, E., Wang, Y., Thorell, A., & Soop, M. (2026). New persistent opioid use after colorectal surgery in Sweden: A nationwide register‐based cohort study. Colorectal Disease. https://doi.org/10.1111/codi.70601
Vancouver
Gedda C, Nygren J, Sturegård E, Wang Y, Thorell A, Soop M. New persistent opioid use after colorectal surgery in Sweden: A nationwide register‐based cohort study. Colorectal Disease. 2026. doi:10.1111/codi.70601
BibTeX
@article{Gedda2026,
author = {Gedda, Claes and Nygren, Jonas and Sturegård, Erik and Wang, Yunzhang and Thorell, Anders and Soop, Mattias},
title = {New persistent opioid use after colorectal surgery in Sweden: A nationwide register‐based cohort study},
journal = {Colorectal Disease},
year = {2026},
doi = {10.1111/codi.70601}
}
EUVIMED